Perturbed proteostasis in autism spectrum disorders. (2016)

First Author: Louros SR
Attributed to:  Targeting ERK and mTOR for the treatment of fragile X syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/jnc.13723

PubMed Identifier: 27365114

Publication URI: http://europepmc.org/abstract/MED/27365114

Type: Journal Article/Review

Volume: 139

Parent Publication: Journal of neurochemistry

Issue: 6

ISSN: 0022-3042